1-Pyrroline-5-carboxylate released by prostate Cancer cell inhibit T cell proliferation and function by targeting SHP1/cytochrome c oxidoreductase/ROS Axis

Overview of attention for article published in Journal for Immunotherapy of Cancer, December 2018

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (67th percentile)

Mentioned by

twitter: 9 X users

Citations

dimensions_citation: 27 Dimensions

Readers on

mendeley: 31 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 27 publications that cite this research output.

27

The most recent citing publications are shown below. View all 27 publications that cite this research output on Dimensions.

Photodynamic Therapy and Adaptive Immunity Induced by Reactive Oxygen Species: Recent Reports

Article in Cancers (February 2024)

1-Pyrroline-5-carboxylate inhibit T cell glycolysis in prostate cancer microenvironment by SHP1/PKM2/LDHB axis

Article in Cell Communication and Signaling (February 2024)

The Role of Tumor Metabolic Reprogramming in Tumor Immunity

Article in International Journal of Molecular Sciences (December 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.